Bipolar.
Conditions
Interventions
Intervention group: Daily reception of a capsule containing Familact made by Zist Takhmir Company for 8 weeks.
Sponsors
Faculty of pharmacy, Shahid Beheshti University of Medical Scienses
Eligibility
Sex/Gender
All
Age
15 Years to 70 Years
Inclusion criteria
Inclusion criteria: Phase I euthymic bipolar patients aged between 15 and 70 years who gave their written consent
Exclusion criteria
Exclusion criteria: Not taking probiotic or synbiotic supplements in the same period before starting the study No history of organic brain diseases Schizophrenia Pregnancy and breastfeeding Active infection convulsions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At the beginning of the study and 60 days after starting tto consume the product containing synbiotics. Method of measurement: Quality of life enjoyment and satisfaction questionnaire.;Quality of life. Timepoint: At the beginning of the study and 60 days after starting tto consume the product containing synbiotics. Method of measurement: WHO quality of life questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognition assessment by COBRA questionaire. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Maria Tavakoli Ardakani
Shahid Beheshti University of Medical Sciences
Outcome results
None listed